Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults
Clinical trial NCT04866069 · TERMINATED
Trial details
- NCT number
- NCT04866069
- Sponsor
- Osman ERGANIS, PhD, Prof
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-25
- Primary completion
- 2021-09-05
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.